<DOC>
	<DOCNO>NCT00002896</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug , give drug different way , combine chemotherapy radiation therapy may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus fluorouracil leucovorin surgery give without fluorouracil leucovorin surgery patient locally advanced rectal cancer .</brief_summary>
	<brief_title>Radiation Therapy Plus Chemotherapy Before Surgery With Without Chemotherapy After Surgery Treating Patients With Rectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess local recurrence rate , cost-benefit ratio , acute late toxicity associate concomitant preoperative radiotherapy fluorouracil/leucovorin ( 5-FU/CF ) patient locally advance adenocarcinoma rectum . II . Compare relapse rate , survival rate , disease-free interval , cost-benefit ratio associate 6 course postoperative 5-FU/CF vs. treatment patient . OUTLINE : This randomize study . Patients stratify tumor stage , age , type surgery , participate institution . Patients randomly assign one two group . The first group receive radiotherapy tumor 5 week concomitant fluorouracil/leucovorin 5 consecutive day first fifth week . Four six week later , patient undergo complete resection , follow upon recovery fluorouracil/leucovorin every 4 week 6 course . The second group receive preoperative chemoradiotherapy follow surgery , , postoperative treatment . Patients follow survival . PROJECTED ACCRUAL : A total 774 patient enter multicenter study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma mucinous adenocarcinoma rectum Distal limit tumor high 12 cm anal verge proctoscopy Locally advance ( T34 M0 ) tumor one following : Partial fixation Complete stenosis Invasion beyond muscular stratum transrectal ultrasound PATIENT CHARACTERISTICS : Age : 75 Performance status : WHO 0 1 Hematopoietic : WBC great 3,000 Platelets great 130,000 Hepatic : Not specify Renal : Creatinine le 1.4 mg/dL Cardiovascular : No unstable angina No cardiac decompensation Other : No prior concurrent malignancy PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>mucinous adenocarcinoma rectum</keyword>
</DOC>